Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The development of cannabinoid antagonists.

F Barth1, M Rinaldi-Carmona

  • 1Sanofi Recherche, 371 rue du Pr Joseph Blayac 34184, Montpellier, Cédex 04, France.

Current Medicinal Chemistry
|September 2, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testing the validity of telephone interviews to assess chronic pain in children and adolescents: A randomized cross-over trial.

European journal of pain (London, England)·2017
Same author

[Therapy outcome one year after pediatric outpatient chronic pain evaluation : Chronic Pain Grading (CPG) for adolescent pain patients].

Schmerz (Berlin, Germany)·2017
Same author

[Therapy recommendations in a pediatric outpatient pain clinic : Adherence and effectiveness of implementation].

Schmerz (Berlin, Germany)·2016
Same author

[Role of cannabinoid receptors in regulation of cardiac tolerance to ischemia and reperfusion].

Izvestiia Akademii nauk. Seriia biologicheskaia·2008
Same author

[Indirect costs in idiopathic Parkinson's disease].

Fortschritte der Neurologie-Psychiatrie·2005
Same author

Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2002

Researchers are developing new cannabinoid antagonists, like diarylpyrazoles, to study the roles of CB1 and CB2 receptors. These compounds show therapeutic potential for various conditions.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Medicinal Chemistry

Background:

  • The discovery of cannabinoid receptors (CB1 and CB2) spurred research into cannabinoid antagonists.
  • Early attempts to find antagonists based on agonist structures were largely unsuccessful.

Purpose of the Study:

  • To review the development and significance of cannabinoid antagonists.
  • To highlight the role of diarylpyrazoles, particularly SR 141716, in understanding CB1 receptor function.
  • To emphasize the emerging therapeutic potential of novel cannabinoid antagonists.

Main Methods:

  • Review of scientific literature on cannabinoid receptor antagonists.
  • Focus on the chemical series of diarylpyrazoles and their selective antagonists.
  • Discussion of pharmacological tools like SR 141716 and SR 144528.

Related Experiment Videos

Main Results:

  • The diarylpyrazole chemical series yielded the first potent cannabinoid antagonists.
  • SR 141716 (selective CB1 antagonist) is a crucial tool for studying CB1 receptors.
  • SR 144528 (selective CB2 antagonist) is anticipated to be vital for CB2 research.

Conclusions:

  • Cannabinoid antagonists, especially from novel chemical series, are valuable pharmacological tools.
  • These compounds are increasingly recognized for their therapeutic potential.
  • Continued development of diverse cannabinoid antagonists is essential for advancing research and drug discovery.